August 2025 Disclaimer 2 The information contained in this presentation is intended solely for your personal reference. Such information is subject to change without notice, its accuracy is not guaranteed and it may not contain all material information concerning Sunny Optical Technology (Group) Company Limited. The Company makes no representation regarding, and assumes no responsibility or liability for, the accuracy or completeness of, or any errors or omissions in, any information contained herein. In ad ...

Financial Performance - The company's revenue reached RMB 2.5 billion, a 19.5% year-over-year increase[13] - F-end and B-end corporate health management revenue totaled RMB 1.96 billion, representing a 30.2% year-over-year growth[13] - Net profit attributable to shareholders of the parent company increased by 136.8% year-over-year to RMB 130 million[13] - Adjusted net profit grew by 83.6% year-over-year to RMB 160 million[13] - Gross margin improved by 1.4 percentage points year-over-year to 33.6%[13] Business Growth and Service Expansion - Users entitled to family doctor service benefits increased by 150% year-over-year, reaching over 35 million[11,39] - The number of F-end paying users grew by 34.6% year-over-year to approximately 20 million[11,32] - B-end paying users increased by 39.2% year-over-year to over 3.6 million[11,35] - Users entitled to home-based senior care benefits increased by 83% year-over-year[11,40] - The company has over 3,500 paying corporate clients, a 37.2% year-over-year increase[11,35] AI and Technology Enablement - AI assistance enables doctors to handle approximately 4 million daily consultation requests[11,46] - AI-assisted inquiry and consultation accuracy rate is nearly 98%[11,46] - AI-driven cuts in family doctors' average service cost per customer by approximately 52% year-over-year[18,47]

Financial Performance Highlights - HKEX achieved record half-yearly revenue and other income of HK$14.1 billion, a 33% year-over-year increase[9] - Profit attributable to shareholders reached HK$8.5 billion in 1H 2025, up 39% year-over-year[11] - Core business revenue increased by 34% year-over-year to HK$13.0 billion in 1H 2025[16] - EBITDA increased by 43% year-over-year to HK$10.9 billion in 1H 2025[16] - Headline Average Daily Turnover (ADT) increased by 118% year-over-year[12] Business Segment Performance - Stock Connect revenue reached a record high of HK$1.813 billion, a 51% year-over-year increase[38] - Northbound Stock Connect ADT increased by 32% year-over-year[12] - Southbound Stock Connect ADT nearly tripled compared to 1H 2024[12] - Derivatives Average Daily Volume (ADV) reached a record half-yearly high of 1.7 million contracts, up 11% year-over-year[12] - LME ADV increased by 3% year-over-year[12] Strategic Initiatives and Market Dynamics - IPO funds raised reached HK$109.4 billion, more than 8 times that of 1H24[38]

Financial Performance - Yancoal reported a revenue of $2.68 billion, a 15% decrease compared to $3.138 billion in 1H 2024 [12, 76] - Operating EBITDA was $595 million, with a 23% margin [12] - Profit after tax reached $163 million, resulting in earnings per share of $0.12 [12] - The company holds $1.8 billion in cash with no interest-bearing loans [12] - An interim dividend of $82 million, or $0.0620 per share, was declared at a 50% payout ratio [12] Production and Operations - ROM coal production was 32.2Mt, a 16% increase from 1H 2024 [12, 28] - Saleable coal production reached 24.8Mt, a 15% increase from 1H 2024 [12, 22] - Attributable saleable coal production was 18.9Mt, an 11% increase compared to 1H 2024 [12, 33] - Cash operating costs decreased by 8% to $93/tonne compared to 1H 2024 [12, 37] Safety - The 12-month rolling Total Recordable Injury Frequency Rate (TRIFR) was 6.32, an improvement from 6.73 at the end of 2024, and remains below the industry weighted average of 7.93 [12, 17]

Financial Performance - Group revenue reached RMB 116.0 billion, a 30.5% year-over-year increase[11] - Gross profit margin was 22.5%, up 1.8 percentage points year-over-year[11] - Adjusted net profit reached RMB 10.8 billion, a 75.4% year-over-year increase[11] - Smart EV, AI and other new initiatives revenue reached RMB 21.3 billion, a 233.9% year-over-year increase[11] Smartphone Business - Global smartphone market share ranked top 3 with 14.7%[16] - Mainland China smartphone market share increased 1.0 percentage point year-over-year to 15.3%[16] - Premium smartphone as a percentage of total smartphone units sold in Mainland China increased 5.5 percentage points year-over-year to 27.6%[16] - Global smartphone shipments reached 42.4 million units[38] IoT and Lifestyle Products - IoT and lifestyle products revenue reached RMB 38.7 billion, up 44.7% year-over-year[79] - Smart large home appliances revenue increased 66.2% year-over-year[16] - Global tablet shipments increased 42.3% year-over-year[16] Smart EV and AI Initiatives - Smart EV sales revenue reached RMB 20.6 billion, up 230.3% year-over-year[84] - Xiaomi EV quarterly delivery reached 81,302 vehicles[16] - Locked-in orders for Xiaomi YU7 series reached 240,000 units in 18 hours[16]

Business Overview & Highlights - 科伦博泰是一家致力于肿瘤学、免疫学和其他治疗领域新药的开发、制造和商业化的生物制药公司[14] - 公司有30多个在研药物，其中4个处于临床阶段，并且有超过1870名全职雇员[20] - 公司有3款产品上市，并且已经提交了5个新药申请(NDAs)[20] - 公司与默沙东就多个ADC资产展开合作，包括SKB410/MK-3120, SKB571/MK-2750, SKB535/MK-6204[30] Commercialization - 公司商业销售总额达3.098 亿元人民币，其中sac-TMT (佳泰莱®)销售占比为97.6%[53] - 公司已组建了一支人数超过350人的营销团队，覆盖30个省份和300多个城市，目标医院数超过2000家[57] - 佳泰莱®已完成29个省挂网，科泰莱®已完成25个省挂网，达泰莱®已完成15个省挂网[62] Financial Performance - 公司收入从2024年上半年的13.82791亿人民币减少到2025年上半年的9.50445亿人民币[85, 95] - 公司毛利从2024年上半年的10.7669亿人民币减少到2025年上半年的6.59988亿人民币[85, 95] - 公司研发费用从2024年上半年的6.52337亿人民币减少到2025年上半年的6.11539亿人民币[89, 95]

Tongcheng Travel Holdings Limited Stock Code: 0780 Investor Presentation August 2025 Disclaimer The materials used in this investors presentation are being furnished to you for your information only, which shall be kept in strict confidence. No representation or warranty, express or implied, is made by Tongcheng Travel Holdings Limited (the "Company") or its connected person, or any of their respective directors, officers, employees, advisers or representatives as to, and no reliance should be placed on, th ...

Financial Performance - Group revenue reached RMB 6838 million, a 71% year-over-year increase[3] - Operating profit increased by 91% to RMB 1305 million, with an operating profit margin of 191%[3] - Profit attributable to ordinary equity holders of the company increased by 215% to RMB 914 million[3] - Basic earnings per share increased by 165% to RMB 346 cents[6] Segment Performance - Mass market revenue increased by 45% to RMB 6053 million[3, 11] - Professional sports revenue increased significantly by 325% to RMB 785 million[3, 11] Balance Sheet Highlights - Net cash and cash equivalents increased significantly by 943% to RMB 1913 million[7] - Shareholders' equity increased by 135% to RMB 9876 million[7] Brand Performance & Strategy - Xtep is the No 1 running brand in China, with leading overall wear rate in major marathons[18, 19] - Core Xtep brand revenue increased, with footwear accounting for 584% of revenue[75] - Saucony & Merrell brands experienced revenue growth, with overall revenue increasing by 325%[83] Sustainability - The company recycled approximately 3000 kg of clothes and reduced carbon emissions by over 10000 kg[52, 53]

(327.HK) PAX Global Technology Limited Interim results 2025 Disclaimer The information contained in these presentation materials has been prepared by PAX Global Technology Limited ( "Company" or "PAX") (incorporated in Bermuda with limited liability) solely for use at the presentation to prospective investors for introduction of the Company. By accepting this document, you are agreeing to maintain absolute confidentiality regarding the information disclosed in this document. This document has not been indep ...

(Stock Code: 1177.HK) (RMB bn) 2025 2025 Interim Results Announcement 2025.8.18 Hong Kong CONTENTS Financial Highlights Pipeline Highlights 2 Financial Highlights Both revenue and profit achieved double-digit growth 1.54 3.09 2024 H1 Continuing Operations 2025 H1 Continuing Operations Revenue 15.87 17.57 2024 H1 Continuing Operations 2025 H1 Continuing Operations Profit attributable to owners of the parent (as reported) 1.41 3.39 2024 H1 Continuing Operations 2025 H1 Continuing Operations Profit attributabl ...